Yagita H - Search Results

1

PD-1 blockade enhances T-cell migration to tumors by elevating IFN-γ inducible chemokines.

Peng W, Liu C, Xu C, Lou Y, Chen J, Yang Y, Yagita H, Overwijk WW, Lizée G, Radvanyi L, Hwu P. Peng W, et al. Among authors: yagita h. Cancer Res. 2012 Oct 15;72(20):5209-18. doi: 10.1158/0008-5472.CAN-12-1187. Epub 2012 Aug 20. Cancer Res. 2012. PMID: 22915761 Free PMC article.

2

Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis is an important endogenous mechanism for resistance to liver metastases in murine renal cancer.

Seki N, Hayakawa Y, Brooks AD, Wine J, Wiltrout RH, Yagita H, Tanner JE, Smyth MJ, Sayers TJ. Seki N, et al. Among authors: yagita h. Cancer Res. 2003 Jan 1;63(1):207-13. Cancer Res. 2003. PMID: 12517799

3

E1A sensitizes cancer cells to TRAIL-induced apoptosis through enhancement of caspase activation.

Shao R, Lee DF, Wen Y, Ding Y, Xia W, Ping B, Yagita H, Spohn B, Hung MC. Shao R, et al. Among authors: yagita h. Mol Cancer Res. 2005 Apr;3(4):219-26. doi: 10.1158/1541-7786.MCR-04-0084. Mol Cancer Res. 2005. PMID: 15831675

4

Cutting Edge: Programmed death (PD) ligand-1/PD-1 interaction is required for CD8+ T cell tolerance to tissue antigens.

Martin-Orozco N, Wang YH, Yagita H, Dong C. Martin-Orozco N, et al. Among authors: yagita h. J Immunol. 2006 Dec 15;177(12):8291-5. doi: 10.4049/jimmunol.177.12.8291. J Immunol. 2006. PMID: 17142723

5

Combined natural killer T-cell based immunotherapy eradicates established tumors in mice.

Teng MW, Westwood JA, Darcy PK, Sharkey J, Tsuji M, Franck RW, Porcelli SA, Besra GS, Takeda K, Yagita H, Kershaw MH, Smyth MJ. Teng MW, et al. Among authors: yagita h. Cancer Res. 2007 Aug 1;67(15):7495-504. doi: 10.1158/0008-5472.CAN-07-0941. Cancer Res. 2007. PMID: 17671220

6

Interleukin 21 enhances antibody-mediated tumor rejection.

Smyth MJ, Teng MW, Sharkey J, Westwood JA, Haynes NM, Yagita H, Takeda K, Sivakumar PV, Kershaw MH. Smyth MJ, et al. Among authors: yagita h. Cancer Res. 2008 Apr 15;68(8):3019-25. doi: 10.1158/0008-5472.CAN-07-6019. Cancer Res. 2008. PMID: 18413772

7

Antigen presented by tumors in vivo determines the nature of CD8+ T-cell cytotoxicity.

Shanker A, Brooks AD, Jacobsen KM, Wine JW, Wiltrout RH, Yagita H, Sayers TJ. Shanker A, et al. Among authors: yagita h. Cancer Res. 2009 Aug 15;69(16):6615-23. doi: 10.1158/0008-5472.CAN-09-0685. Epub 2009 Aug 4. Cancer Res. 2009. PMID: 19654302 Free PMC article.

8

PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors.

Curran MA, Montalvo W, Yagita H, Allison JP. Curran MA, et al. Among authors: yagita h. Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4275-80. doi: 10.1073/pnas.0915174107. Epub 2010 Feb 16. Proc Natl Acad Sci U S A. 2010. PMID: 20160101 Free PMC article.

9

Blockade of programmed death-1 pathway rescues the effector function of tumor-infiltrating T cells and enhances the antitumor efficacy of lentivector immunization.

Zhou Q, Xiao H, Liu Y, Peng Y, Hong Y, Yagita H, Chandler P, Munn DH, Mellor A, Fu N, He Y. Zhou Q, et al. Among authors: yagita h. J Immunol. 2010 Nov 1;185(9):5082-92. doi: 10.4049/jimmunol.1001821. Epub 2010 Oct 6. J Immunol. 2010. PMID: 20926790 Free PMC article.

10

Anti-TIM3 antibody promotes T cell IFN-γ-mediated antitumor immunity and suppresses established tumors.

Ngiow SF, von Scheidt B, Akiba H, Yagita H, Teng MW, Smyth MJ. Ngiow SF, et al. Among authors: yagita h. Cancer Res. 2011 May 15;71(10):3540-51. doi: 10.1158/0008-5472.CAN-11-0096. Epub 2011 Mar 23. Cancer Res. 2011. PMID: 21430066

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,034 results

Search Page

Filters